Skip to main navigation Skip to search Skip to main content

B‐cell acute lymphocytic leukemia in HIV‐antibody‐positive patients

  • Jay E. Gold
  • , Antonio Castella
  • , Ralph Zalusky

Research output: Contribution to journalArticlepeer-review

Abstract

B‐cell non‐Hodgkin lymphoma (NHL) has been well described in association with human immunodeficiency virus (HIV) and the acquired immunodeficiency syndrome (AIDS). Many of these lymphomas are of the diffuse, aggressive, subtype of B‐cell NHL, including Burkitt and Burkitt‐like lymphoma. Recently, there have been reports of B‐cell acute lymphocytic leukemia (ALL), Burkitt type, in patients who were either HIV antibody‐positive or at high risk for AIDS. We have seen three cases of B‐cell ALL, Burkitt type, and herein describe their clinical and laboratory characteristics. All patients were HIV antibody‐positive. Since stage IV Burkitt lymphoma in blood phase and B‐cell ALL, Burkitt type, represent a continuum of the same disease, and since it is also an aggressive B‐cell malignancy, we suggest that B‐cell ALL, Burkitt type, in HIV antibody‐positive patients should support the diagnosis of AIDS.

Original languageEnglish
Pages (from-to)200-204
Number of pages5
JournalAmerican Journal of Hematology
Volume32
Issue number3
DOIs
Publication statusPublished - Nov 1989
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • AIDS
  • Burkitt lymphoma
  • B‐cell ALL
  • HIV‐related lymphoma

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'B‐cell acute lymphocytic leukemia in HIV‐antibody‐positive patients'. Together they form a unique fingerprint.

Cite this